Back to Authors

Sweeney, Christopher

Mayo Clinic

Dana-Farber/Harvard Cancer Center

Citations 2

Impact on overall survival (OS) with chemohormonal therapy versus hormonal therapy for hormone-sensitive newly metastatic prostate cancer (mPrCa): An ECOG-led phase III randomized trial.
Sweeney, Christopher, Liu, Glenn , Jarrard, David Frasier, Eisenberger, Mario A. , Wong, Yu‐Ning, Hahn, Noah M. , Cooney, Matthew M. , Shevrin, Daniel H. , García, Jorge A. , DiPaola, Robert S. , Chen, Yu‐Hui , Carducci, Michael A. , Kohli, Manish , Vogelzang, Nicholas J. , Dreicer, Robert , Picus, Joel , Hussain, Maha

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: LBA2-LBA2

10.1200/jco.2014.32.15_suppl.lba2 Get It